Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-25

Clinical Trial Update: Pro-2-Cool Pivotal Trial II [NA]

View source ↗

Summary

TecTraum Inc. reports that the pivotal trial II for Pro-2-Cool in mild traumatic brain injury is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pro-2-Cool

Snippet

Sponsor: TecTraum Inc. | Conditions: Mild Traumatic Brain Injury | NA | Status: SUSPENDED